Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-015788

Director sold 19,142 shares at $2.93 ($56,086)

  • Director acquired 24,720 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ANDREWS DEBORAH J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-29 Exercise or conversion : show line 1 in the form +24,720 $2.20 $54,384 34,720 D
2021-06-29 Sale : show line 2 in the form −19,142 $2.93 $56,086 15,578 D
Open-market sales · 19,142 sh · avg $2.93 · $56,086

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-29 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −24,720 0 D
Loading xslF345X03/ownership.xml…